Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-82.41%Return on Equity
VS
Market
Sector
Industry
History
$ 1.52Close
$ 1.51 - $ 9.22 52-Week Range
Ticker Information
Ticker
LUNGCompany Name
PULMONX CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQPULMONX CORP - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LUNG - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 69.09M | $ -56.94M | -82.41% |
| 3/31/2025 | $ 77.67M | $ -57.09M | -73.51% |
| 12/31/2024 | $ 85.81M | $ -56.39M | -65.72% |
| 9/30/2024 | $ 93.92M | $ -57.11M | -60.8% |
| 6/30/2024 | $ 101.18M | $ -57.86M | -57.19% |
| 3/31/2024 | $ 110.5M | $ -58.73M | -53.15% |
| 12/31/2023 | $ 118.31M | $ -60.84M | -51.42% |
| 9/30/2023 | $ 125.74M | $ -61.24M | -48.7% |
| 6/30/2023 | $ 133.95M | $ -60.51M | -45.17% |
| 3/31/2023 | $ 143.93M | $ -58.95M | -40.96% |
Key Performance Insights, Last 5 Years
- PULMONX CORP's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, PULMONX CORP's average ROE has been -43.94%.
- The median ROE for PULMONX CORP during this period was -43.07%
- PULMONX CORP reached its highest ROE over the past 5 years at -14.25%.
- The lowest ROE recorded by PULMONX CORP in the same timeframe -82.41%
PULMONX CORP's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for PULMONX CORP is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ -206.89M ]
(=) ROE [ 0% ] LUNG - Return on Equity, Last 5 years
-82.41%
Minimum
Jun 30, 2025
-14.25%
Maximum
Dec 31, 2020
-43.94%
Average
-43.07%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |